Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Archives of Neurology
|
April 12, 2006
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis
E M Frohman, E Havrdova, F Lublin, et al.
Neurology
|
April 15, 2011
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
R Zivadinov, K Marr, G Cutter, et al.
Journal of Neurology
|
March 7, 2023
Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study
R Veldkamp, M D'hooge, B M Sandroff, et al.
Multiple Sclerosis and Related Disorders
|
August 30, 2024
Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis
L Connolly, S Chatfield, J Freeman, et al.
Neurology
|
April 6, 2011
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution
M Filippi, M A Rocca, F Camesasca, et al.
Neuroimage. Clinical
|
September 30, 2021
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial
D Ontaneda, P Sati, P Raza, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 27, 2016
Extended interval dosing of natalizumab in multiple sclerosis
L Zhovtis Ryerson, T C Frohman, J Foley, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Archives of Neurology
|
April 12, 2006
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis
E M Frohman, E Havrdova, F Lublin, et al.
Neurology
|
April 15, 2011
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
R Zivadinov, K Marr, G Cutter, et al.
Journal of Neurology
|
March 7, 2023
Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study
R Veldkamp, M D'hooge, B M Sandroff, et al.
Multiple Sclerosis and Related Disorders
|
August 30, 2024
Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis
L Connolly, S Chatfield, J Freeman, et al.
Neurology
|
April 6, 2011
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution
M Filippi, M A Rocca, F Camesasca, et al.
Neuroimage. Clinical
|
September 30, 2021
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial
D Ontaneda, P Sati, P Raza, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 27, 2016
Extended interval dosing of natalizumab in multiple sclerosis
L Zhovtis Ryerson, T C Frohman, J Foley, et al.
Page
of 11